newsfilter
← Latest News
ACCESS Newswire·

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / December 16, 2025 / Lexaria Bioscience Corp. ) , a global innovator in drug delivery platforms, today announced the closing of its